About Neurava
Neurava is a Healthcare company based in West Lafayette (United States) founded in 2019 by Jay Shah and Vivek Ganesh. Remote monitoring platform for epilepsy patients. It operates in the Healthcare and Technology sectors. Neurava has raised $5.78 million across 5 funding rounds from investors including UCB, Life Science Angels and Purdue Innovates. Its chief executive, as recorded, is Jay Shah. Neurava offers products and services including Epilepsy Wearables. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring. Its legal entity is Neurava Inc. Its competitors include Endotronix, Edwards Lifesciences and CoachCare; 2 of its 3 listed competitors have raised funding.
Company details
Neurava was founded in 2019 in West Lafayette, United States, focusing on health technology for epilepsy management. Operations center on remote monitoring devices that assess SUDEP risk, enable nighttime surveillance, and support expedited treatment responses. Wearable solutions and seizure alert systems are offered to patients and caregivers, with services extending to broader alert management protocols in the epilepsy sector.
- Headquarters West Lafayette, United States
- Founders Jay Shah, Vivek Ganesh
- SectorsHealthcareTechnology
- Website neurava.com
- Social LinkedIn
- Legal Name Neurava Inc
- Total Equity Funding$5.78M (USD)
in 5 rounds
- Latest Funding Round$1.6M (USD), Seed
Oct 2025
- InvestorsUCB
& 6 more
Products & Services of Neurava
Neurava offers a comprehensive portfolio of products and services, including Epilepsy Wearables.
Wearables that detect epilepsy signals and alert for SUDEP risks.
Funding Insights of Neurava
Neurava has successfully raised a total of $5.78M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $1.6 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.78M
- Total Rounds 5
- Last Round Seed — $1.6M
- First Round $20,000
(Jun 2019)
- Investors Count 7
All 5 funding rounds of Neurava with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $1.6M | Seed | – | – | – |
| Apr 2024 | $2.26M | Seed | – | Life Science Angels | |
| Jan 2023 | $1.24M | Seed | – | – | – |
| Sep 2021 | $656,250 | Seed | – | Elevate Ventures | |
| Jun 2019 | $20,000 | Seed | – | Elevate Ventures | – |
7 investors in total: 7 institutional.
Investors in Neurava
Neurava has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include UCB, Life Science Angels and Purdue Innovates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life sciences startups are funded by a non-profit angel network. | lifescienceangels.com | Sunnyvale, United States | ||
Early-stage investments are made in diverse sectors by the firm. | elevateventures.com | Indianapolis, United States | ||
Capital is invested in startups and small businesses by First Leaf Capital. | firstleafcapital.com | Champaign-Urbana, United States | ||
Support for technology commercialization and startup development is provided. | purduefoundry.com | West Lafayette, United States | ||
Therapies for immunological and neurological disorders are developed. | 1928 | ucb.com | Brussels, Belgium | |
Purdue Innovates is focused on supporting technology commercialization and entrepreneurship. | purdueinnovates.org | West Lafayette, United States | ||
Early-stage MedTech startups are funded and supported by iO Life Ventures. | iolifeventures.com |
Investor details for Neurava
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neurava
2 people are tracked at Neurava (2 in leadership).
| Name | Role | Group |
|---|---|---|
Jay Shah | Co-Founder & CEO | Leadership |
Vivek Ganesh | Co-Founder | Leadership |
Complete people profiles for Neurava
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neurava
3 dated milestones of Neurava across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Neurava is founded.
- Funding First funding round of $20K.
- Funding Latest funding round, Seed, of $1.6M.
Competitors of Neurava
Neurava has 3 listed competitors in our database, 2 of them funded. They include Endotronix, Edwards Lifesciences and CoachCare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endotronix.com | 2007 | East Peoria, United States | $154.77M | 104 | Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | |
| edwards.com | 1958 | Irvine, United States | 19,800 | Medical devices for structural heart disease are developed and provided. | ||
| coachcare.com | 2013 | New York, United States | $60.2M | Remote monitoring platform for tracking patient activity |
Detailed competitors of Neurava
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Neurava
The website of Neurava (neurava.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 35.2% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Neurava (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurava
Complete news archive for Neurava
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurava
Neurava was founded in 2019.
Neurava is headquartered in West Lafayette, United States. It is registered at West Lafayette, Indiana, United States.
Jay Shah is the CEO of Neurava, as recorded in our data. They have also founded this company.
Neurava is a funded company, having raised a total of $5.78M across 5 funding rounds to date. The company's 1st funding round was a Seed of $20K, raised on Jun 2019.
Neurava was founded in 2019 in West Lafayette, United States, focusing on health technology for epilepsy management. Operations center on remote monitoring devices that assess SUDEP risk, enable nighttime surveillance, and support expedited treatment responses. Wearable solutions and seizure alert systems are offered to patients and caregivers, with services extending to broader alert management protocols in the epilepsy sector.
Neurava's top competitors include Endotronix, CoachCare and Edwards Lifesciences.
Neurava offers Epilepsy Wearables.
Neurava has 7 investors. Key investors include UCB, Life Science Angels, Purdue Innovates, Elevate Ventures, and First Leaf Capital.
Neurava operates through Neurava Inc.